American Thyroid Association. Scientists & Physicians Dedicated to Better Understanding & Treatment of Thyroid Diseases.

ATA Committees And Task Forces 2008-2009

Print page Email page

Click on the committee title for a description.

Awards Committee
Sandra McLachlan, Chair (2007-2009)
Douglas Forrest (2007-2010)
David Gardner (2006 – 2009)
Jerome Hershman (2008-2011)
Jacqueline Jonklaas (2008-2011)
Robert Smallridge (2006 - 2009)
Yaron Tomer (2008-2011)
Ulla Feldt-Rasmussen, Corresponding
Rebecca Bahn, Board Liaison

Bylaws Committee - Board Level
Antonio Bianco, Chair (2008-2009)
Carol Greenlee, Board member
Edward Merker, Member

Clinical Affairs Committee
Mira Milas, Chair (2008 – 2009)
Peter Angelos (2007-2010)
Ernest Asamoah (2007-2010)
Harvey Cohen (2007-2010)
Diana Dean (2007-2010)
Loren Wissner Greene (2008-2011)
Mark Lupo (2008 – 2011)
David Rosenthal (2008-2011)
Brendan Stack (2007-2010)
Michael Thomas (2007-2010)
William Valente (2008-2011)
Sandra Daniela Licht, Corresponding
Carol Greenlee, Board Liaison

CME and Guidelines Committee
Peter Kopp, Chair (2007-2009)
David Cooper (2008-2011)
Gilbert Daniels (2007-2011)
Steven Hodak (2008-2011)
Mary Samuels, Board Liaison

Development Task Force
Steven Sherman, Chair
Hossein Gharib (2008-2009)
Bryan McIver (2008-2009)
Leonard Wartofsky (2008-2009)
Lawrence Wood (2008-2009)
David Sarne, Board Liaison

Ethics Committee
Pepper Davis, Chair
Glenn Braunstein (2008-2011)
Martin Surks (2008-2011)
Ethicist - Stuart Finder
Ethicist – Andrew Peach
Kenneth Burman, Board Liaison

Finance and Audit Committee – Board level
David H. Sarne, Chair (2006 – 2011)
Mary Samuels, Board member
Georg Kahaly (2007-2010)
Douglas Ross (2008-2011)
Stephen Spaulding (2008-2011)
Paul Woolf (2005 – 2009)

Guidelines: Thyroid Cancer & Nodules Rev.
David S. Cooper, Chair
Gerard M. Doherty
Bryan R. Haugen
Richard Kloos
Stephanie L. Lee
Susan J. Mandel
Ernest Mazzaferri
Bryan McIver
Furio Pacini
Martin Schlumberger
Steven I. Sherman
David Steward
R. Michael Tuttle

Guidelines: Hyperthyroidism
Rebecca Bahn, Chair
Henry Burch
David Cooper
Jeff Garber
Carol Greenlee
Irwin Klein
Peter Laurberg
Ross McDougall
Scott Rivkees
Doug Ross
Julie Ann Sosa

Guidelines: Medullary Thyroid Cancer
Richard Kloos, Chair
Charis Eng
Douglas Evans
Gary Francis
Robert Gagel
Hossein Gharib
Jeffrey Moley
Furio Pacini
Matthew Ringel
Martin Schlumberger
Sam Wells

History and Archives Committee
Joel Ehrenkranz, Chair (2004 – 2009)
Robert J. Anderson (2005 – 2009)
Marguerite Hays (2004 – 2009)
James Magner (2006 – 2009)
Geraldo Medeiros-Neto (2005 – 2009)
Robert Segal (2005 – 2009)
Woody Sistrunk (2007-2010)
John B. Stanbury (2004 – 2009)
Ian Hay, Board Liaison

International Thyroid Congress
Coordinating Committee

Kenneth Burman, ex officio (2008-2009)
Richard T. Kloos ex officio (2007 – 2011)
Program Organizing Committee (POC)
(ATA representatives)
Antonio Bianco (2007-2010)
Steven Sherman (2007-2010)
Yaron Tomer (2007-2010)

Internet Communications Task Force
Victor Bernet, Chair (2007– 2009)
Matthew Kim (2006-2009)
Rebecca Leboeuf (2008-2009)
Pamela Schroeder (2008-2009)
Steven Waguespack (2008-2009)
Michael Tuttle, Board Liaison

Lab Services Committee
John Morris, Chair (2004-2009)
Kenneth Ain (2007-2010)
Ronald Ghossein (2008-2011)
Manjula Gupta (2007-2010)
George Klee (2008-2011)
Howard Lando (2006 – 2009)
Nicole Massoll (2005 – 2009)
Jerald C. Nelson (2004 – 2009)
Ivana Petrovic (2007-2010)
Carole Spencer (2004-2009)
Furio Pacini, Corresponding 2008
Michael McDermott, Board Liaison

 

Meeting: Spring Symposium Committee
Pregnancy and Thyroid

Alex Stagnaro-Green, Co-Chair
Elizabeth Pearce, Co-chair
Gregory Brent, Research Summit Chair
Erik Alexander
Coleen Boyle, CDC
Rosalind Brown
Susan Mandel
Jorge Mestman
Joann Rovet
Offie Soldin
Scott Sullivan, ACOG
Kenneth Burman, ex officio

Meeting: Frontiers in Thyroid Cancer II:
ATA Guidelines in Clinical Practice
Richard Kloos, Chair
Ernest Mazzaferri, Co-chair
Gerard M. Doherty
Stephanie L. Lee
Susan J. Mandel
Steven Sherman, CME Program Director

Meeting: Annual Meeting Program Committee
Matthew Ringel, Basic Chair
Kathryn Schuff, Clinical Chair
Erik Alexander (2008-2011)
Salvatore Benvenga (2008-2011)
Henry Burch (2008-2011)
Sally Carty (2007-2010)
Patrizio Caturegli (2006-2009)
Francesco Celi (2008 – 2011)
Anthony Hollenberg (2009 -2011)
Sissy Jhiang (2008-2011)
Peter Kopp (2006-2009)
Virginia LiVolsi (2007-2010)
Michael McDermott (2006–2009)
Honey Reddi (2007-2010)
Ralph Tufano (2008-2011)
Douglas Van Nostrand (2008-2011)
Su He Wang (2007-2010)

Membership Panel
Virginia Sarapura, Chair
Terry Davies, ex officio
H. Lester Reed (2008-2011)
James Fagin, Board Liaison

Nominating Committee
Susan Mandel, Chair (2007 – 2009)
Lewis Braverman (2007-2010)
Rosalind Brown (2007-2010)
Bryan Haugen (2007-2010)
Monica Skarulis (2008-2011)
Julie Ann Sosa (2007-2010)
Donald St. Germain (2006 – 2009)
John Turco (2008-2011)
Richard T. Kloos, Board Liaison

Patient Education and Advocacy Committee
Chair: Alan Farwell, Board member
Ruth Belin (2008-2011)
Glenn Braunstein (2008-2011)
Regina Castro (2008-2011)
Frank Crantz (2008-2011)
Jamshid Farahati (2008-2011)
Heather Hofflich (2007-2010)
Jennifer Loh (2008-2011)
M. Sara Rosenthal (2006 – 2009)
Mona Sabra (2008-2011)
Jerrold Stock (2008-2011)
Whitney Woodmansee (2008-2011)
Valeria Guimaraes, Corresponding

Publications Committee
Chair: Matthew Ringel, Board member
Grant Anderson (2008-2011)
Frances Carr (2007-2010)
Joshua Cohen (2008 – 2011)
Henry Fein (2006 – 2009)
Yolanda C. Oertel (2008-2011)
Joshua Safer (2006 – 2009)
Robert Smallridge (2006 – 2009)
Charles Emerson, THYROID, ex officio
Ernest Mazzaferri, Clinical Thyroidology, ex officio
Ralf Paschke, Corresponding

Public Health Committee
Elizabeth Pearce, Chair (2008 – 2009)
Anca Avram (2008-2011)
Gerard Burrow (2006 – 2009)
Charlene Edinboro (2007-2010)
Andrew Gianoukakis (2007-2010)
James Hennessey (2007 – 2010)
Scott Rivkees (2007-2010)
Elaine Ron (2008-2011)
Arthur Schneider (2008-2011)
Jack Wall (2007-2010)
Jason Wexler (2008-2011)
David V. Becker, Advisor
Lester Van Middlesworth, Advisor
Michael Zimmermann, Corresponding
Antonio Bianco, Board Liaison

Public Relations Committee
Rebecca Bahn, Chair, ex officio
Terry Davies, ex officio
Greg Brent (2008-2011)
Orlo Clark (2008-2011)
Steve Hodak (2008-2011)
Carole Spencer (2008-2011)
Bobbi Smith, ex officio

Research Committee
Irwin L. Klein, (Chair 2005 – 2009)
Marcia Brose (2007 – 2010)
Sheue-yann Cheng (2008-2011)
John Copland (2006 – 2009)
Quan-Yang Duh (2008 – 2011)
Valerie Anne Galton (2007-2010)
Reigh Yi Lin (2007-2010)
Jennifer Rosen (2006 – 2009)
Christine Spitzweg (2007-2010)
David Steward (2007-2010)
Mark Urken (2007-2010)
Mingzhao Xing (2005 – 2009)
Martha Zeiger (2007-2010)
Matthias Schott, Corresponding
Terry Davies, Board Liaison

Surgical Task Force
R. Michael Tuttle, Chair
Andrew Bauer (2008 – 2009)
Sally Carty (2008 – 2009)
David Cooper (2008 – 2009)
Alan Dackiw (2008 – 2009)
Jacqueline Jonklaas (2008 – 2009)
Ernest Mazzaferri (2008 – 2009)
Ralph Tufano (2008 – 2009)
Sam Wells (2008 – 2009)
Rob Udelsman (2008 – 2009)
Endre Nagy, Corresponding

Trainees and Career Advancement
Gregory Brent, Chair
Victor Bernet (2008-2011)
Diana Dean (2008-2011)
Andrew Gianoukakis (2008-2011)
Jennifer Loh (2008-2011)
Susan Mandel (2008-2011)
Stephanie Fish (2009 Clinical Track Co-chair)
Ann Marie Zavacki (2009 Basic Track Co-chair)
Ken Burman, Board liaison


Awards Committee: The Awards Committee shall consist of up to ten members. Six members shall constitute a quorum.

The Awards Committee shall select the recipients of the Van Meter Award, the Sidney H. Ingbar Distinguished Lectureship, the Paul Starr Award, the Distinguished Service Award and the John B. Stanbury Thyroid Pathophysiology Medal. Nominations forms are found on the ATA website www.thyroid.org, in the Annual Meeting Program book, and from the ATA office upon request.

1. The Van Meter Prize Lecture Award is given each year to an outstanding investigator who is not older than the age of 45 in the year of the award. The criterion for selection is excellence of research in thyroidology. The recipient shall be selected from nominations made by the Association membership. The Board of Directors strongly encourages the ATA membership to nominate worthy candidates.

2. The Sidney H. Ingbar Distinguished Lectureship is endowed by contributions to honor the memory of Sidney H. Ingbar. The award will be given to an established investigator who has made major contributions in thyroid or related research over many years in keeping with the innovation and vision which epitomized Dr. Ingbar's brilliant investigative career. The recipient shall be selected from nominations made by the Association membership. The name of the recipient will be announced each year at the time of the address given during the scientific session at the annual meeting.

3. The Paul Starr Award Lecture is given each year to acknowledge an outstanding contributor to clinical thyroidology. The recipient shall be selected from nominations made by the Association membership.

4. The Distinguished Service Award is given each year to a member who has made important and continuing contributions to the Association. This nomination requires only a CV and sponsorship letter noting the nominee’s service to the ATA.

5. The John B. Stanbury Thyroid Pathophysiology Medal recognizes outstanding research contributions to the understanding of thyroid physiology or the pathophysiology of thyroid disease. The significance of these contributions will be evidenced by their major impact on subsequent research or clinical practice related to thyroid disorders. The award is not restricted to members of the American Thyroid Association. The medal will be conferred at the annual meeting banquet.

Return to the committee list

Bylaws Committee:The Bylaws Committee will consist of up to four members, chaired by a board member.

The Bylaws Committee shall examine the Bylaws and Recommend appropriate changes to the Board and membership. The Bylaws committee shall keep a record of all bylaws changes recommended by the membership at annual meeting in order to incorporate them into written proposed amendments. The proposed amendments must be presented in writing to the membership 60 days before the annual business meeting. A two-thirds vote or more of members present will be required for passage.
Read the ATA Bylaws (ATA members only)

Return to the committee list

Clinical Affairs Committee: The Clinical Affairs Committee shall consist of up to nine members.

The Clinical Affairs Committee shall review issues relevant to standards of practice in thyroid disease and update publications and other recommendations relating to practice guideline, which have been published on behalf of the Association regarding practice guidelines. The Committee shall also receive, review, and prepare responses to matters affecting the practice of clinical thyroidology, in coordination with the Public Health Committee. Clinical Affairs Committee members may be asked to represent the Association on practice, regulatory, and reimbursement issues.

CME and Guidelines Committee:

1. Advise and support the ATA staff on obtaining and maintaining CME accreditation status.

2. Expand CME opportunities from ATA efforts and enduring materials such as our meetings and fellowship track activities, publications (including Clinical Thyroidology), and Guidelines. Work with staff to invite faculty to provide CME questions for program presentations and, when necessary, create and review questions for CME certification purposes.

3. Generate and prioritize new proposals for Guidelines, and the need to update existing Guidelines. Create a short list of candidates to chair each Guideline effort.

Development Task Force: The Development Committee will consist of four members. The Treasurer shall be an ad hoc member of this committee.

The Development Committee is to coordinate, propose, and investigate methods by which endowments and income can be increased to the Association.

Return to the committee list

Finance and Audit Committee:

1. The Finance and Audit Committee shall consist of five to seven members, chaired by the Treasurer. Three members shall constitute a quorum.

2. The Finance and Audit Committee shall examine all books, vouchers, statements or appropriate reports of the Treasurer at least once yearly. If requested, they shall advise and aid the Treasurer in his/her efforts to arrange examinations, reviews or audits.

3. The Finance and Audit Committee shall maintain a continuing overview of the financial affairs of the Association and shall make such recommendations to the Board of Directors, as it deems appropriate concerning the fiscal management of the Association.

4. The Finance and Audit Committee shall recommend a spending policy for ATA Endowment Funds which:

  1. requires expert financial counsel
  2. always has an explicitly defined spending limit

History and Archives Committee: The History and Archives Committee shall consist of an unspecified number of members.

The History and Archives Committee shall obtain, collate, file, and record relevant information pertaining to past, present, or future events of the Association. Photographs, audiovisual materials, and copies, or original data, of programs, abstracts, distinguished lectures, or the like, should be maintained at the Association's administrative office.

Return to the committee list

International Coordinating Committee: The International Coordinating Committee shall consist of up to six members. The Secretary of the Association shall be an ad hoc member. The term of office will be five years. Two members may have their term extended to six years at the discretion of the President.

The International Coordinating Committee will work closely with each of the other Thyroid Associations to help propose meeting sites and times and to help coordinate all relevant scientific, economic, and geographical considerations relevant to International Meetings.

Membership ‘Panel':

1. The Membership Panel shall consist of 2-3 members.

2. It is the duty of the Membership Committee to receive and review all applications for membership in the Association. The major criterion for membership shall be evidence of scholarly interest in the thyroid gland. The names of those applicants whose credentials fulfill the requirements for membership and are approved for membership by majority vote of the members of the committee shall be referred to the Board of Directors.

3. The Membership Committee through the Secretary shall inform in writing both those applicants who have been rejected or held over and their sponsors of the action of the committee and the reason for that decision.

4. Additional information in support of applicants held over may be submitted by their sponsors.

5. No application for membership shall be rejected until reviewed by the Membership Committee for three consecutive years.

Nominating Committee:

1. The Nominating Committee shall consist of seven members. Five members shall constitute a quorum.

2. After ascertaining willingness to serve on the part of the potential nominees, the Nominating Committee shall nominate at least two members for the offices of President and directors. The nominating committee shall notify the Secretary of those members nominated at least 75 days prior to each annual meeting. The Secretary shall then notify the membership of the proposed candidates for elective office. Within the next thirty days, nominations by petition for elective office may be submitted. Such petitions require the signatures of at least 5% of the active members. Ballots are to be sent to the membership thirty days in advance of the annual meeting.

3. If nominated, the Nominating Committee chairperson and members may not stand as a candidate for any office during his or her tenure on the Committee.

Return to the committee list

Patient Education and Advocacy Committee: The Patient Education and Advocacy Committee shall consist of nine members. Five members shall constitute a quorum. Clinicians and clinical researchers with an interest in patient education should comprise the majority of the committee members.

The Patient Education and Advocacy Committee will be concerned with all aspects of patient education as directed by the ATA’s Strategic Plan. In particular, the committee shall be concerned with ATA Website Excellence, Expansion of Collaborations and Development and Implementation of a Patient Information and Outreach Plan. Committee actions to achieve these goals include the following:

i) Write, edit and update the patient education brochures on the ATA website, subject to Board approval
ii) Review and update the content on the patient education site on the ATA website
iii) Outreach and collaboration with lay patient education groups
iv) Collaboration with sister professional societies with regard to thyroid patient education
v) Participate in the organization, development and presentation of education programs targeted to thyroid patients and the public

Program Committee:

1. The Annual Program Committees shall consist of ten members, three of which are appointed each year so that each standing member has a three-year term. In general, the Chairman shall have been a committee member for two years. Up to ten ad hoc members may be appointed by the President solely for the purpose of reviewing abstracts for an upcoming meeting. Six members shall constitute a quorum.

2. The Program Committee shall select from abstracts submitted to it those topics, subjects, or papers that are to be presented at the scientific meetings of the Association and to arrange their order of presentation.

3. No abstract, a major portion of which has been published or read before any other national or international meeting in North America shall be considered for presentation on the scientific program of the Association unless by special permission of the Program Committee.

4. The committee may with the consent of the Board of Directors arrange for invited lectures or symposia as part of the scientific program.

5. The Program committee shall provide a copy of the program to the Secretary in ample time to allow its printing and distribution prior to the annual meeting of the Association. All accepted abstracts will be published unless withdrawn by the author.

6. The Secretary shall inform those who have submitted abstracts and titles for the program of the action of the committee as quickly as possible after its deliberations.

Public Health Committee: The committee shall consist of up to ten members, with seven representing a quorum.

It is the duty of this committee to receive, review, and prepare responses to information relevant to public health issues and the thyroid. Committee members may be asked to represent the Association at public forums.

Return to the committee list

Publications Committee: The Publications Committee shall consist of up to seven members appointed by the President. The term of office is three years with two to three members to be replaced each year. The Editors-in Chief shall be ex officio members without vote of this committee.

The Publications Committee will work closely with Board to coordinate the relationship between the Association, the Editors-in-Chief and the publishers of Association publications not owned by the association. The Committee will have oversight over all the American Thyroid Association publications, print and electronic, distributed beyond the membership

The Committee will:
(i) Determine the overall content of the publications and the policies governing publication, and provide guidance and advice to the Editors.
(ii) Establish policies and procedures for selection of the Editors-in-Chief, determine their terms of service and negotiate their contracts. Nominees for Editors-in-chief are to be approved by Board.
(iii) Respect the editorial independence of the editors.
(iv) Review and approve the budget and financial records of the editorial offices
(v) Serve as an interface between the Association and its Editors-in-Chief and the publishers. This will include negotiation of contracts and oversight of financial records.

Research Committee: The Research Committee shall consist of seven to nine plus ad hoc members. Five members shall constitute a quorum.

The Research Committee shall be concerned with the following areas:
i) Develop Research Grant Announcements for posting in the Journal, newsletter and on the website
ii) Develop deadlines, guidelines, and timelines for proposal submission
iii) Rank proposals according to their scientific merit and relevance to their designated area of research
iv) Review proposals for grant applications.
v) Invite authors of selected proposals to submit complete grant applications using the NIH format.
vi) Review submitted grant applications and determines which grants will be funded.

Ad Hoc or Temporary Committees: The President shall appoint temporary or ad hoc committees as necessary for the fulfillment of the aims of the Association.

All ad hoc or temporary committees are terminated with the ending of the term in office of the President who made the appointment.

A report of the activities of each ad hoc committee shall be presented in writing to the Board of Directors and, at the discretion of the President, an oral report shall be given to the members at the annual meeting.

Return to the committee list

Privacy Policy | Terms & Conditions | Contact Us
Site Design by Intertwine Systems, Inc.